‘Safe and effective’: Heart Failure Society of America urges patients to get COVID-19 vaccine

Michael Walter | | Cardiovascular Business | COVID-19
Covid Vaccine

The Heart Failure Society of America (HFSA) has issued a statement on the importance of the newly approved COVID-19 vaccines, noting that “patients with heart failure should be confident that the vaccines will help to address the ongoing pandemic and help protect patients from the coronavirus.”

Thousands of patients, including President-elect Joe Biden and numerous other government leaders, have already received a COVID-19 vaccine. The HFSA noted that the Pfizer/BioNTech vaccine is for individuals 16 years old or older. The Moderna/NIH vaccine, on the other hand, is targeted at individuals 18 years old and older.

“Heart failure healthcare professionals have been on the front lines battling COVID-19 and its consequences,” Nancy Albert, PhD, RN, president of the Heart Failure Society of America, said in a statement. “We have learned a lot about clinical care and infection control. Being vaccinated is an important step in prevention. We are now well positioned to let patients with heart failure know that both COVID-19 vaccines are safe and effective.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

AHA issues a scientific statement on COVID-19 cardiac arrhythmias
History of COVID-19 doubles long-term risk of heart attack, stroke or death
Monitoring acute heart patients at home linked to considerable cost savings
A key update on how COVID-19 caused dangerous MIS-C inflammation in children
Q&A: Cardiologist Karen Joynt Maddox on why new healthcare policies are not improving outcomes
COVID-19 vaccines helped heart failure patients stay out of the hospital and live longer

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."